Date: 2014-08-18 16:56:02

Private equity

Venture capital

Business Development Bank of Canada

Collective investment scheme

Financial economics

Investment

Finance

FOR IMMEDIATE RELEASE Xagenic Announces Second Closing of $25.5M Series B Financing Toronto, ON (July 14, 2014) – Xagenic Inc., a molecular diagnostics company developing the first labfree molecular diagnostic platfor

Document is deleted from original location.
Use the Download Button below to download from the Web Archive.

File Size: 114,01 KB